NI
NKTR icon

Numeric Investors’s Nektar Therapeutics NKTR Stock Holding History

Numeric Investors’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,533
Closed -$912K – 1140
2017
Q3 		$912K Sell
2,533
-26,849
-91% -$8.4M 0.01% 773
2017
Q2 		$8.62M Buy
29,382
+28,053
+2,111% +$8.11M 0.08% 240
2017
Q1 		$468K Sell
1,329
-4,178
-76% -$939K ﹤0.01% 805
2016
Q4 		$1.01M Buy
+5,507
New +$1.12M 0.01% 661
2015
Q2 		– Sell
-7,211
Closed -$1.19M – 1032
2015
Q1 		$1.19M Sell
7,211
-9,793
-58% -$2.01M 0.01% 437
2014
Q4 		$3.95M Sell
17,004
-18,365
-52% -$3.93M 0.05% 256
2014
Q3 		$6.4M Buy
35,369
+2,933
+9% +$561K 0.09% 191
2014
Q2 		$6.24M Buy
32,436
+9,506
+41% +$1.68M 0.09% 209
2014
Q1 		$4.17M Buy
22,930
+7,330
+47% +$1.45M 0.07% 249
2013
Q4 		$2.66M Sell
15,600
-10,820
-41% -$1.75M 0.04% 314
2013
Q3 		$4.14M Buy
26,420
+19,960
+309% +$3.69M 0.08% 236
2013
Q2 		$1.12M Buy
+6,460
New +$991K 0.02% 388

Other funds holding NKTR

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Numeric Investors's NKTR Position: Q4 2017 in Review

Numeric Investors sold out of Nektar Therapeutics (NKTR) in Q4 2017, closing a stake of 2,533 shares — an estimated $912K sold.

Numeric Investors first reported a position in NKTR in Q2 2013 and held it in 12 quarters. The position peaked at $8.62M in Q2 2017. 265 funds tracked by Wall St. Rank hold NKTR as of Q4 2017.

  • Numeric Investors reported no remaining Nektar Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Numeric Investors sold 2,533 Nektar Therapeutics shares in Q4 2017, an estimated $912K.
  • Numeric Investors first reported a position in Nektar Therapeutics in Q2 2013 and held it in 12 quarters.
  • Numeric Investors's Nektar Therapeutics position peaked at $8.62M in Q2 2017.
  • 265 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.